DK2723774T3 - Fremgangsmåde til fremstilling af hydroxyethylstivelses-derivater - Google Patents

Fremgangsmåde til fremstilling af hydroxyethylstivelses-derivater Download PDF

Info

Publication number
DK2723774T3
DK2723774T3 DK12737229.0T DK12737229T DK2723774T3 DK 2723774 T3 DK2723774 T3 DK 2723774T3 DK 12737229 T DK12737229 T DK 12737229T DK 2723774 T3 DK2723774 T3 DK 2723774T3
Authority
DK
Denmark
Prior art keywords
hydroxyethyl
procedure
manufacture
style
derivatives
Prior art date
Application number
DK12737229.0T
Other languages
English (en)
Inventor
Werner Zimmermann
Jan Lukowczyk
Original Assignee
Serumwerk Bernburg Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44799422&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2723774(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Serumwerk Bernburg Ag filed Critical Serumwerk Bernburg Ag
Application granted granted Critical
Publication of DK2723774T3 publication Critical patent/DK2723774T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00Preparation of derivatives of starch
    • C08B31/08Ethers
    • C08B31/12Ethers having alkyl or cycloalkyl radicals substituted by heteroatoms, e.g. hydroxyalkyl or carboxyalkyl starch
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00Preparation of derivatives of starch
    • C08B31/08Ethers
    • C08B31/10Alkyl or cycloalkyl ethers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00Preparation of derivatives of starch
    • C08B31/18Oxidised starch
    • C08B31/185Derivatives of oxidised starch, e.g. crosslinked oxidised starch

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK12737229.0T 2011-06-21 2012-06-21 Fremgangsmåde til fremstilling af hydroxyethylstivelses-derivater DK2723774T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11170761A EP2537866A1 (en) 2011-06-21 2011-06-21 Hydroxyethyl starch derivatives, method for manufacturing the same and therapeutical uses thereof
PCT/EP2012/061958 WO2012175608A1 (en) 2011-06-21 2012-06-21 Method for manufacturing hydroxyethyl starch derivatives

Publications (1)

Publication Number Publication Date
DK2723774T3 true DK2723774T3 (da) 2019-07-15

Family

ID=44799422

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12737229.0T DK2723774T3 (da) 2011-06-21 2012-06-21 Fremgangsmåde til fremstilling af hydroxyethylstivelses-derivater

Country Status (21)

Country Link
US (2) US9181353B2 (da)
EP (2) EP2537866A1 (da)
JP (2) JP6370217B2 (da)
CN (2) CN103649128B (da)
BR (1) BR112013032901A2 (da)
CA (1) CA2837784C (da)
CY (1) CY1121976T1 (da)
DK (1) DK2723774T3 (da)
ES (1) ES2733767T3 (da)
HK (1) HK1220218A1 (da)
HR (1) HRP20191173T1 (da)
HU (1) HUE044428T2 (da)
LT (1) LT2723774T (da)
MX (1) MX337682B (da)
PL (1) PL2723774T3 (da)
PT (1) PT2723774T (da)
RS (1) RS59021B1 (da)
SI (1) SI2723774T1 (da)
TR (1) TR201909574T4 (da)
TW (1) TWI564010B (da)
WO (1) WO2012175608A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6616725B2 (ja) * 2016-03-31 2019-12-04 日本製紙株式会社 塗工紙用澱粉
AU2020206021A1 (en) 2019-01-10 2021-07-22 Pharmacosmos Holding A/S Treating iron deficiency in subjects at risk of cardiovascular adverse events and iron for the management of atrial fibrillation
EA202191858A1 (ru) 2019-06-12 2021-11-12 Фармакосмос Холдинг А/С Лечение дефицита железа у субъектов с риском нежелательных явлений со стороны сердечно-сосудистой системы и железо для лечения фибрилляции предсердий
WO2023012242A1 (en) 2021-08-03 2023-02-09 Pharmacosmos Holding A/S Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals
CN117547549A (zh) * 2023-11-09 2024-02-13 黑龙江八一农垦大学 适用于犬arf的腹膜透析液与助清除剂的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639588A (en) * 1966-10-22 1972-02-01 Fisons Pharmaceuticals Ltd Pharmaceutical compositions containing ferric hydroxide complexed with dextran or dextrin heptonic acids
US4370476A (en) * 1979-07-17 1983-01-25 Usher Thomas C Dextran polycarboxylic acids, ferric hydroxide complexes
GB8902894D0 (en) * 1989-02-09 1989-03-30 Fisons Plc Compositions
JPH0566372A (ja) * 1991-09-10 1993-03-19 Fukui Megane Kogyo Kk 金属製眼鏡フレーム部品の製造方法
JPH0776524A (ja) * 1993-07-13 1995-03-20 Takeda Chem Ind Ltd 動物用抗貧血剤
DK172860B1 (da) 1998-03-25 1999-08-16 Pharmacosmos Holding As Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
JP3504506B2 (ja) 1998-09-17 2004-03-08 株式会社荏原製作所 消音装置
DK173138B1 (da) * 1998-11-20 2000-02-07 Pharmacosmos Holding As Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma
EP1762250A1 (en) * 2005-09-12 2007-03-14 Fresenius Kabi Deutschland GmbH Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine
US8399705B2 (en) * 2007-08-17 2013-03-19 Akzo Nobel N.V. Alkali metal salt of glutamic acid N,N-diacetic acid, a process to prepare such salt, and the use thereof
TWI469965B (zh) * 2008-12-22 2015-01-21 Ono Pharmaceutical Co 乙炔基吲哚化合物
JP5397991B2 (ja) * 2009-04-01 2014-01-22 学校法人東京農業大学 乳酸菌を用いたビタミンb12の定量方法

Also Published As

Publication number Publication date
HRP20191173T1 (hr) 2019-10-04
HUE044428T2 (hu) 2019-10-28
TWI564010B (zh) 2017-01-01
JP2014520188A (ja) 2014-08-21
ES2733767T3 (es) 2019-12-02
PL2723774T3 (pl) 2019-10-31
CA2837784A1 (en) 2012-12-27
TR201909574T4 (tr) 2019-08-21
MX337682B (es) 2016-03-15
EP2723774B1 (en) 2019-04-03
US20140128594A1 (en) 2014-05-08
US20160046733A1 (en) 2016-02-18
BR112013032901A2 (pt) 2017-01-24
MX2013015075A (es) 2014-04-14
SI2723774T1 (sl) 2019-08-30
US9631032B2 (en) 2017-04-25
CN103649128B (zh) 2016-02-10
EP2537866A1 (en) 2012-12-26
CA2837784C (en) 2019-10-15
JP6370217B2 (ja) 2018-08-08
EP2723774A1 (en) 2014-04-30
CY1121976T1 (el) 2020-10-14
PT2723774T (pt) 2019-07-15
JP2018100424A (ja) 2018-06-28
CN103649128A (zh) 2014-03-19
WO2012175608A1 (en) 2012-12-27
RS59021B1 (sr) 2019-08-30
TW201315474A (zh) 2013-04-16
CN105348401A (zh) 2016-02-24
LT2723774T (lt) 2019-08-12
HK1220218A1 (zh) 2017-04-28
US9181353B2 (en) 2015-11-10

Similar Documents

Publication Publication Date Title
DK3225604T3 (da) Fremgangsmåde til fremstilling af flerlagsruder
DK2718404T3 (da) Fremgangsmåde til fremstilling af flydende carbonhydrider
DK2768796T3 (da) Fremgangsmåde til fremstilling af quinolin-derivater
DK3520805T3 (da) Sammensætninger til behandling af myelofibrose
CO6890099A2 (es) Nuevos derivados dihidroquinolina-2-ona
DK3235812T3 (da) Deutererede derivater af ivacaftor
DK2718403T3 (da) Fremgangsmåde til fremstilling af flydende carbonhydrid
DK2739293T3 (da) Fremgangsmåder og sammensætninger til frembringelse af vaccinavirus
DK2814849T3 (da) Fremgangsmåde til fremstilling af cyclodextrin-derivater
BR112013019509A2 (pt) derivados heterocíclicos
DK3210978T3 (da) Fremgangsmåde til fremstilling af acesulfamkalium
CO6801764A2 (es) Derivados de pirazol
DK2623288T3 (da) Fremgangsmåde til fremstilling af formstøbte skumdele
DK2595948T3 (da) Fremgangsmåde til fremstilling af ingenol-3-angelat
DK2785801T4 (da) Fremgangsmåde til formindskelse af isdannelse på et underlag
DK2836460T3 (da) Fremgangsmåde til fremstilling af graphen
DK2834229T3 (da) Fremgangsmåde til fremstilling af ccr3-inhibitorer
DK2794849T3 (da) Fremgangsmåde til fremstilling af svækkede salmonellastammer med højt udbytte
BR112014009761A2 (pt) composição oftálmica
DK2701707T3 (da) Fremgangsmåde til behandling af dyskinesi
DK2474236T3 (da) Fremgangsmåde til fremstilling af søde sager
NO20110238A1 (no) Fremgangsmåte for fremstilling av aminoalkoholer
DK2920151T3 (da) Fremgangsmåde til fremstilling af carboxamider
DK2723774T3 (da) Fremgangsmåde til fremstilling af hydroxyethylstivelses-derivater
DK3284479T3 (da) Fremgangsmåde til fremstilling af medikamenter til bekæmpelse af tumorer